Clinical Trials Directory

Trials / Completed

CompletedNCT01394406

Effect of Ketamine Added to Intravenous Patient-controlled Analgesia on Postoperative Pain, Nausea and Vomiting in Patients Undergoing Lumbar Spinal Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Ketamine added to intravenous patient-controlled analgesia may be effective on prevention of postoperative nausea and vomiting by reducing opioid requirement after surgery.

Conditions

Interventions

TypeNameDescription
DRUGKetamineketamine 3 mg/kg mixed to intravenous patient controlled analgesia device (fentanyl 20 mcg/kg. total volume 180 ml, basal infusion 2 ml, bolus 2ml, lock-out 15 min)
DRUGSalineequal volume of normal saline mixed to intravenous patient controlled analgesia device

Timeline

Start date
2010-01-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2011-07-14
Last updated
2014-03-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01394406. Inclusion in this directory is not an endorsement.